Recently, Tianjin Yuyun Medical Technology Co., Ltd. has proudly declared the successful conclusion of a funding round that has surpassed 100 million yuan. This significant funding initiative was spearheaded by CICC Capital and Wuxi Innovation Investment, with additional financial backing from existing shareholder Chengdu Science and Technology Innovation Investment. Established in 2016, Yuyun Medical has carved out a niche for itself by specializing in the research and development, manufacturing, and marketing of cutting-edge equipment and catheters, including intravascular ultrasound and optical coherence tomography systems. Armed with a diverse array of technological platforms, the company offers holistic solutions tailored to the needs of vascular interventions. Moreover, Yuyun Medical has broadened its horizons to encompass a range of imaging systems, with certain cardiac ultrasound systems on the verge of entering the registration phase. A pertinent official from CICC Capital remarked that this investment marks a pivotal milestone in their strategic blueprint within the domestic vascular intervention landscape. They harbor high hopes for Yuyun Medical's capacity to shatter overseas monopolies and are confident that it will emerge as a driving force behind the import substitution and widespread clinical adoption of domestically manufactured high-end medical devices.